Hi Daz - I am not calling $0.52c good. I am calling $0.35c good. Those rough prices are my conservative calculations and are based on the revenue forecasts contained in the Maxim report of July last year. They state that their model only includes cardiocel in CHD and heart valve repair. No allowance for vaccines or vascucel or the curved patch. Maxim had a $2.00 target price. I certainly hope that the share price will be well north of $0.52c by 2018.
Patersons Research - BUY, page-56
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.05 |
Change
-0.100(0.66%) |
Mkt cap ! $289.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $54.06K | 3.559K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 356 | 3 |
View Market Depth
| Last trade - 14.04pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |